Dr. Rosensweet began practicing medicine in the 1970s and is now a thought leader in holistic health, nutrition, and patient-centered care. A nationally recognized lecturer and presenter, he’s also the author of The Menopause Method and founder of his latest health venture: I Wonder, Doctor, a free informational website that helps empower patients through carefully crafted video content. His work addresses the most common ailments Americans face today, including diabetes, menopause, and anxiety and depression, and Dr. Rosensweet has recently begun selling his own line of natural, medical-grade vitamins and supplements to help treat these ailments and improve the health of patients across the country.

Kent Holtorf, M.D. is the medical director of the Holtorf Medical Group and a founder and director of the non-profit National Academy of Hypothyroidism (NAH), which is dedicated to dissemination of new information to doctors and patients on the diagnosis and treatment of hypothyroidism and advanced integrative diagnostic and treatment protocols. He has personally trained numerous physicians across the country in the use of bioidentical hormones, hypothyroidism, complex endocrine dysfunction and innovative treatments of chronic fatigue syndrome, weight loss, fibromyalgia and chronic infectious diseases, including Lyme and related diseases. Lyme and associated diseases has been the focus of the Holtorf Medical Group centers and has been a passion of Dr. Holtorf for well over ten years.

 

Dr. Merzenich is the brain behind BrainHQ and the author of Soft-Wired: How the New Science of Brain Plasticity Can Change Your Life. For nearly five decades, he has been a leading pioneer in brain plasticity research. As co-founder and Chief Scientific Officer of Posit Science, Michael Merzenich heads the company’s science team.

Dr. Merzenich has published more than 150 articles in leading peer-reviewed journals (such as Science and Nature), and received numerous awards and prizes (including the Russ Prize, Ipsen Prize, Zülch Prize, Thomas Alva Edison Patent Award and Purkinje Medal). He has been granted nearly 100 patents, and he and his work have been highlighted in hundreds of books about the brain, learning, rehabilitation, and plasticity. In 2016, Dr. Merzenich was awarded one of the world’s top neuroscience prizes, the Kavli Prize, for his achievements in the field of brain plasticity.

Dr. Merzenich’s work is also often covered in the popular press, including the New York Times, the Wall Street Journal, Time, Wired, Forbes, Discover, and Newsweek. He has appeared extensively on television. He is the scientific consultant and provided the brain assessments and brain training exercises for the Discovery Channel show “Hack My Brain” (which aired in Australia as “Redesign My Brain.”) His work has also been featured on four PBS specials: “The Brain Fitness Program,” “Brain Fitness 2: Sight and Sound,” “The New Science of Learning,” and “Brain Fitness Frontiers.”

Dr. Merzenich earned his bachelor’s degree at the University of Portland and his PhD at Johns Hopkins. He completed a post-doctoral fellowship at the University of Wisconsin in Madison before becoming a professor at the University of California, San Francisco. In 2007, he retired from his long career at UCSF as Francis A. Sooy Professor and Co-Director of the Keck Center for Integrative Neuroscience. He was elected to the National Academy of Sciences in 1999 and the Institute of Medicine in 2008.

In the late 1980s, Dr. Merzenich was on the team that invented the cochlear implant, now distributed by market leader Advanced Bionics. In 1996, Dr. Merzenich was the founding CEO of Scientific Learning Corporation (Nasdaq: SCIL), which markets and distributes software that applies principles of brain plasticity to assist children with language learning and reading.

 

Dr. Bercik graduated as MD from Charles University, Prague, Czechoslovakia. He obtained a fellowship from the Swiss National Foundation to work with Professors Pavel Kucera and Andre Blum at the University of Lausanne, Switzerland, where he studied myogenic and neural control of gastrointestinal motility as a theme of his doctoral thesis. After clinical residency training in Charles University and the Central Military hospital in Prague, he worked as postdoctoral research and clinical fellow at McMaster University with Professor Stephen Collins focusing on animal models of functional gastrointestinal diseases and the role of low grade inflammation on gut function. Currently, he is Associate Professor in the Department of Medicine, Division of Gastroenterology, and director of Clinical Motility Laboratory and Celiac Clinic at McMaster University. His basic and clinical research, funded by CIHR and NIH, investigates the role of intestinal bacteria in gut-brain axis signaling, and its pathogenic importance in functional gastrointestinal diseases and gluten-related disorders. He has published over 80 peer-reviewed papers, with current h-index of 39.

Russ Jaffe is Founder and Chairman of PERQUE Integrative Health, LLC (PIH, www.PERQUE.com) a company that offers the world scientifically proven, integrative health solutions to speed the transition from sick care to healthful caring.

Dr. Jaffe has more than 40 years of experience contributing to molecular biology and clinical diagnostics. His focus is on functional, predictive tests and procedures designed to improve the precision of both diagnosis and of treatment outcomes and he has authored nearly 100 articles on the subject. He received his B.S., MD and Ph.D. from the Boston University School of Medicine, completed residency training in clinical chemistry at the National Institutes of Health and remained on the permanent senior staff before pursuing other interests, including starting the Health Studies Collegium think tank.

Dr. Jaffe is board certified in Clinical Pathology and in Chemical Pathology. He is the recipient of the Merck, Sharp & Dohm Excellence in Research Award, the J.D. Lane Award, and the U.S.P.H.S. Meritorious Service Award. Dr Jaffe was honored as an International Scientist of 2003 by the IBC, Oxford, England, UK for his lifetime contributions to clinical medicine, biochemistry, immunology, methodology, and integrative health policy. He is widely published and sought to explain complex subjects to any audience.  Dr. Jaffe is also founder and chairman of ELISA/ACT Biotechnologies, and MAGique BioTherapeutics.